- XTNT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Xtant Medical (XTNT) CORRESPCorrespondence with SEC
Filed: 4 Oct 10, 12:00am
Attention: | Lisa Sellars | |
Re: | Bacterin International Holdings, Inc. Item 4.01 Form 8-K Filed September 24, 2010 File No. 333-158426 | |
1. | SEC Comment: Please revise paragraph (a)(ii) to disclose whether Uniack’s reports on the financial statements for either of the years ended December 31, 2008 and 2009 contained an adverse opinion or a disclaimer of opinion or were qualified or modified as to uncertainty, audit scope, or accounting principles and describe the nature of each such adverse opinion, disclaimer of opinion, modification, or qualification. Refer to paragraph (a)(1)(ii) of Item 304 of Regulation S-K. In this regard, we note that Uniack’s report on your financial statements for the year ended December 31, 2008 contained an explanatory paragraph regarding your ability to continue as a going concern. |
Company Response: In response to the Staff’s comment, the Company has revised paragraph (a)(ii) in Amendment No. 1 to the Current Report on Form 8-K filed with the Commission on the date hereof to provide the following disclosure: | |
2. | SEC Comment: Please file an updated letter from Uniack as an exhibit to the amendment filed in response to our comments in accordance with Items 304(a)(3) and 601(b)(16) of Regulation S-K. |
· | the Company is responsible for the adequacy and accuracy of the disclosure in the filing; |
· | Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and |
· | the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely, /s/ John P. Gandolfo John P. Gandolfo Chief Financial Officer | |